JPS5735185B1 - - Google Patents

Info

Publication number
JPS5735185B1
JPS5735185B1 JP4209072A JP4209072A JPS5735185B1 JP S5735185 B1 JPS5735185 B1 JP S5735185B1 JP 4209072 A JP4209072 A JP 4209072A JP 4209072 A JP4209072 A JP 4209072A JP S5735185 B1 JPS5735185 B1 JP S5735185B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4209072A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5735185B1 publication Critical patent/JPS5735185B1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP4209072A 1971-04-30 1972-04-26 Pending JPS5735185B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13912071A 1971-04-30 1971-04-30

Publications (1)

Publication Number Publication Date
JPS5735185B1 true JPS5735185B1 (enExample) 1982-07-27

Family

ID=22485216

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4209072A Pending JPS5735185B1 (enExample) 1971-04-30 1972-04-26

Country Status (23)

Country Link
US (1) US3758683A (enExample)
JP (1) JPS5735185B1 (enExample)
BE (1) BE782651A (enExample)
CA (1) CA976085A (enExample)
CH (1) CH566784A5 (enExample)
CS (1) CS209458B2 (enExample)
DD (1) DD100708A5 (enExample)
DE (1) DE2219635C3 (enExample)
DK (1) DK131760C (enExample)
ES (1) ES402176A1 (enExample)
FI (1) FI49773C (enExample)
FR (1) FR2134658B1 (enExample)
GB (1) GB1385086A (enExample)
HU (1) HU166989B (enExample)
IL (1) IL39181A (enExample)
NL (1) NL178258C (enExample)
NO (1) NO137178C (enExample)
PL (1) PL86966B1 (enExample)
RO (1) RO64387A (enExample)
SE (1) SE378066B (enExample)
SU (1) SU508162A3 (enExample)
YU (1) YU36155B (enExample)
ZA (1) ZA722243B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
FI882921L (fi) * 1986-10-20 1988-06-17 Novo Industri As Protaminzink-insulinpreparat.
CA1339416C (en) * 1987-02-25 1997-09-02 Liselotte Langkjaer Insulin derivatives
DE19726167B4 (de) * 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
US6624141B1 (en) 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
HUE068164T2 (hu) 2008-10-17 2024-12-28 Sanofi Aventis Deutschland Egy inzulin és egy GLP-1 agonista kombinációja
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
CA2780460C (en) 2009-11-13 2018-09-04 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
RS55378B1 (sr) 2010-08-30 2017-03-31 Sanofi Aventis Deutschland Upotreba ave0010 za proizvodnju leka za tretman diabetes mellitus tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
BR112014004726A2 (pt) 2011-08-29 2017-04-04 Sanofi Aventis Deutschland combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI758239B (zh) 2014-12-12 2022-03-21 德商賽諾菲阿凡提斯德意志有限公司 甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
EP3474820B1 (en) 2017-08-24 2024-02-07 Novo Nordisk A/S Glp-1 compositions and uses thereof
PE20230819A1 (es) 2020-02-18 2023-05-19 Novo Nordisk As Composiciones y usos de glp-1
CN118949061A (zh) * 2023-08-07 2024-11-15 浙江大学 一种糖响应鱼精蛋白胰岛素及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5038E (fr) * 1904-03-09 1905-12-02 Georges Frederic Brade Perfectionnements dans la fabrication des organes du métronome
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form

Also Published As

Publication number Publication date
IL39181A0 (en) 1972-06-28
FI49773C (fi) 1975-10-10
YU36155B (en) 1982-02-25
DD100708A5 (enExample) 1973-10-05
CH566784A5 (enExample) 1975-09-30
NL178258B (nl) 1985-09-16
RO64387A (fr) 1979-07-15
US3758683A (en) 1973-09-11
CS209458B2 (en) 1981-12-31
NO137178C (no) 1978-01-18
DE2219635B2 (de) 1980-11-27
YU114272A (en) 1981-06-30
IL39181A (en) 1974-09-10
GB1385086A (en) 1975-02-26
FR2134658A1 (enExample) 1972-12-08
NL7205865A (enExample) 1972-11-01
BE782651A (fr) 1972-10-26
DK131760C (da) 1976-02-02
FR2134658B1 (enExample) 1975-10-17
CA976085A (en) 1975-10-14
NO137178B (no) 1977-10-10
SE378066B (enExample) 1975-08-18
PL86966B1 (enExample) 1976-06-30
ZA722243B (en) 1973-11-28
FI49773B (enExample) 1975-06-30
DK131760B (da) 1975-09-01
ES402176A1 (es) 1975-03-01
HU166989B (enExample) 1975-07-28
DE2219635C3 (de) 1981-10-15
NL178258C (nl) 1986-02-17
SU508162A3 (ru) 1976-03-25
DE2219635A1 (de) 1972-11-09

Similar Documents

Publication Publication Date Title
FR2134658B1 (enExample)
ATA136472A (enExample)
AR196074A1 (enExample)
AU2691671A (enExample)
AU2564071A (enExample)
AU3005371A (enExample)
AU2941471A (enExample)
AU2485671A (enExample)
AR199640Q (enExample)
AU1109576A (enExample)
AU2588771A (enExample)
AU2577671A (enExample)
AU2486471A (enExample)
AU2930871A (enExample)
AU2456871A (enExample)
AU2503871A (enExample)
AU2455871A (enExample)
AU2415871A (enExample)
AU2963771A (enExample)
AU3025871A (enExample)
AU3038671A (enExample)
AR192311Q (enExample)
AU2399971A (enExample)
AR202997Q (enExample)
AU2473671A (enExample)